Skip to content
Delayed ~15 min

BBNX BETA BIONICS

Permanent stock page ↗

Health Care · Russell 2000

Next earnings: not announced yet

What 18 analyst firms say about BETA BIONICS: their latest ratings, price targets and how far the stock is from them. How it works

15.70 USD+0.21 (+1.36%) today
Price as of 6 Nov 16:00 ET

Analyst window: Latest analyst report within last 1 year

Analyst view · last 1Y

+54.0%to the avg target 24.17 USD+8.47 USD
Buy 12 · Hold 4 · Sell 0

16 rated views · 18 analyst/firm records · 18 firms

Latest report28 Oct 2026avg report date 7 Sep
Target rangePrice is below every target

Radar score

  • Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8064
  • Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8057

Recent analyst activity · last 90 days

Our tracked history has 18 reports on BBNX from 13 analyst firms in the last 90 days (18 firms in the past year).

Comparing each firm's latest target with its previous one: 5 raised their price target, 3 left it unchanged and 2 have their first observed target in the past year.

No firm's latest available rating differs from its previous one.

Latest observed target change: TD Cowen raised its target from $17.00 (set 27 Jan 2026) to $21.00 on 28 Oct 2026.

Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

FirmAnalystLatest ratingReport dateLatest target (USD)
BairdJeff JohnsonHold15 Sep 202616.00 USD
Bank of America SecuritiesTravis SteedHold15 Sep 202620.00 USD
BarclaysChristopher PasqualeBuy6 Oct 202630.00 USD
Goldman SachsDavid RomanBuy15 Jul 202619.00 USD
JefferiesMichael ToomeyBuy12 Oct 202630.00 USD
Ladenburg ThalmannJeffrey S CohenBuy30 Jul 202630.40 USD
Lake Street Capital MarketsFrank TakkinenBuy30 Jul 202620.00 USD
Leerink PartnersMike KratkyBuy14 Sep 202627.00 USD
Piper SandlerMatt O'BrienBuy28 Oct 202624.00 USD
StifelJonathan BlockBuy22 Apr 202620.00 USD
TD CowenMathew BlackmanHold28 Oct 202621.00 USD
TruistRichard NewitterBuy28 Oct 202628.00 USD
UBSPatrick WoodBuy15 Sep 202625.00 USD
Weiss RatingsUnnamed analyst—18 Aug 2026—
Wells FargoLarry BiegelsenBuy23 Sep 202628.00 USD
William BlairSteven LichtmanConflictConflicting reports · excluded21 Aug 2026—
Wolfe ResearchMike PolarkBuy15 Sep 2026Conflicting reports · excluded
Data feed RESEARCHResearch TeamHold15 Jun 2026—

Partial coverage · checked 6 Nov (6 Nov 2026, 06:10 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.